|
1
|
Okumura R, Kurakawa T, Nakano T, Kayama H,
Kinoshita M, Motooka D, Gotoh K, Kimura T, Kamiyama N, Kusu T, et
al: Lypd8 promotes the segregation of flagellated microbiota and
colonic epithelia. Nature. 532:117–121. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hsu C, Okumura R and Takeda K: Human LYPD8
protein inhibits motility of flagellated bacteria. Inflamm Regen.
37:232017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Okumura R and Takeda K: Roles of
intestinal epithelial cells in the maintenance of gut homeostasis.
Exp Mol Med. 49:e3382017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nishino K, Nishida A, Inoue R, Kawada Y,
Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, et al:
Analysis of endoscopic brush samples identified mucosa-associated
dysbiosis in inflammatory bowel disease. J Gastroenterol.
53:95–106. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Terzić J, Grivennikov S, Karin E and Karin
M: Inflammation and colon cancer. Gastroenterology. 138:2101–2114.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu Y, Han ZP, Zhang SS, Jing YY, Bu XX,
Wang CY, Sun K, Jiang GC, Zhao X, Li R, et al: Effects of
inflammatory factors on mesenchymal stem cells and their role in
the promotion of tumor angiogenesis in colon cancer. J Biol Chem.
286:25007–25015. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Waldner M and Neurath M: Master regulator
of intestinal disease: IL-6 in chronic inflammation and cancer
development. Semin Immunol. 26:75–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu X, Huang C, He X, Tian YY, Zhou DX, He
Y, Liu XH and Li J: Feedback regulation of telomerase reverse
transcriptase: New insight into the evolving field of telomerase in
cancer. Cell Signal. 25:2462–2468. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oh H and Ghosh S: NF-κB: Roles and
regulation in different CD4+ T-cell subsets. Immunol
Rev. 252:41–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De Simone V, Franzè E, Ronchetti G,
Colantoni A, Fantini MC, Di Fusco D, Sica GS, Sileri P, MacDonald
TT, Pallone F, et al: Th17-type cytokines, IL-6 and TNF-α
synergistically activate STAT3 and NF-κB to promote colorectal
cancer cell growth. Oncogene. 34:3493–3503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cortez M, Carmo LS, Rogero MM, Borelli P
and Fock RA: A high-fat diet increases IL-1, IL-6, and TNF-α
production by increasing NF-κB and attenuating PPAR-γ expression in
bone marrow mesenchymal stem cells. Inflammation. 36:379–386. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garbers C, Aparicio-Siegmund S and
Rose-John S: The IL-6/gp130/STAT3 signaling axis: Recent advances
towards specific inhibition. Curr Opin Immunol. 34:75–82. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Siveen KS, Sikka S, Surana R, Dai X, Zhang
J, Kumar AP, Tan BK, Sethi G and Bishayee A: Targeting the STAT3
signaling pathway in cancer: Role of synthetic and natural
inhibitors. Biochim Biophys Acta. 1845:136–154. 2014.PubMed/NCBI
|
|
14
|
Chen J, Wang J, Lin L, He L, Wu Y, Zhang
L, Yi Z, Chen Y, Pang X and Liu M: Inhibition of STAT3 signaling
pathway by nitidine chloride suppressed the angiogenesis and growth
of human gastric cancer. Mol Cancer Ther. 11:277–287. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yu H, Lee H, Herrmann A, Buettner R and
Jove R: Revisiting STAT3 signalling in cancer: New and unexpected
biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang C, Yang G, Jiang T, Zhu G, Li H and
Qiu Z: The effects and mechanisms of blockage of STAT3 signaling
pathway on IL-6 inducing EMT in human pancreatic cancer cells in
vitro. Neoplasma. 58:396–405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu J, Zhu C, Zhang Y, Jiang N, Li S, Su Z,
Akaike T and Yang J: hE-cadherin-Fc fusion protein coated surface
enhances the adhesion and proliferation of human mesenchymal stem
cells. Colloids Surf B Biointerfaces. 109:97–102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gleeson M, Bishop NC, Stensel DJ, Lindley
MR, Mastana SS and Nimmo MA: The anti-inflammatory effects of
exercise: Mechanisms and implications for the prevention and
treatment of disease. Nat Rev Immunol. 11:607–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Elinav E, Nowarski R, Thaiss C, Hu B, Jin
C and Flavell RA: Inflammation-induced cancer: Crosstalk between
tumours, immune cells and microorganisms. Nat Rev Cancer.
13:759–771. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Balkwill FR and Mantovani A:
Cancer-related inflammation: Common themes and therapeutic
opportunities. Semin Cancer Biol. 22:33–40. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Erreni M, Mantovani A and Allavena P:
Tumor-associated macrophages (TAM) and inflammation in colorectal
cancer. Cancer Microenviron. 4:141–154. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Allaire JM, Morampudi V, Crowley SM, Stahl
M, Yu H, Bhullar K, Knodler LA, Bressler B, Jacobson K and Vallance
BA: Frontline defenders: Goblet cell mediators dictate host-microbe
interactions in the intestinal tract during health and disease. Am
J Physiol Gastrointest Liver Physiol. 314:G360–G377. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Popko K, Gorska E, Stelmaszczyk-Emmel A,
Plywaczewski R, Stoklosa A, Gorecka D, Pyrzak B and Demkow U:
Proinflammatory cytokines Il-6 and TNF-α and the development of
inflammation in obese subjects. Eur J Med Res. 15
(Suppl):S120–S122. 2010.
|
|
25
|
Mihara M, Hashizume M, Yoshida H, Suzuki M
and Shiina M: IL-6/IL-6 receptor system and its role in
physiological and pathological conditions. Clin Sci. 122:143–159.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McAllister SS and Weinberg RA: The
tumour-induced systemic environment as a critical regulator of
cancer progression and metastasis. Nat Cell Biol. 16:717–727. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guan YQ, Li Z and Liu JM: Death signal
transduction induced by co-immobilized TNF-α plus IFN-γ and the
development of polymeric anti-cancer drugs. Biomaterials.
31:9074–9085. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Emi Aikawa N, de Carvalho JF, Artur
Almeida Silva C and Bonfá E: Immunogenicity of anti-TNF-alpha
agents in autoimmune diseases. Clin Rev Allergy Immunol. 38:82–89.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zamarron BF and Chen W: Dual roles of
immune cells and their factors in cancer development and
progression. Int J Biol Sci. 7:651–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Guo Y, Xu F, Lu T, Duan Z and Zhang Z:
Interleukin-6 signaling pathway in targeted therapy for cancer.
Cancer Treat Rev. 38:904–910. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Neurath MF and Finotto S: IL-6 signaling
in autoimmunity, chronic inflammation and inflammation-associated
cancer. Cytokine Growth Factor Rev. 22:83–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin L, Hutzen B, Zuo M, Ball S, Deangelis
S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, et al: Novel
STAT3 phosphorylation inhibitors exhibit potent growth-suppressive
activity in pancreatic and breast cancer cells. Cancer Res.
70:2445–2454. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lü L, Tang D, Wang L, Huang LQ, Jiang GS,
Xiao XY and Zeng FQ: Gambogic acid inhibits TNF-α-induced invasion
of human prostate cancer PC3 cells in vitro through PI3K/Akt and
NF-κB signaling pathways. Acta Pharmacol Sin. 33:531–541. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ben-Neriah Y and Karin M: Inflammation
meets cancer, with NF-κB as the matchmaker. Nat Immunol.
12:715–723. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miller S, Huang R, Sakamuru S, Shukla SJ,
Attene-Ramos MS, Shinn P, Van Leer D, Leister W, Austin CP, Xia M,
et al: Identification of known drugs that act as inhibitors of
NF-kappaB signaling and their mechanism of action. Biochem
Pharmacol. 79:1272–1280. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wan F and Lenardo MJ: The nuclear
signaling of NF-kappaB: Current knowledge, new insights, and future
perspectives. Cell Res. 20:24–33. 2010. View Article : Google Scholar : PubMed/NCBI
|
